Cholecystectomy increases reflect lower threshold for operation -- JAMA study.
This article was originally published in The Gray Sheet
Executive Summary
CHOLECYSTECTOMY 22% INCREASE SINCE INTRODUCTION OF LAPAROSCOPIC PROCEDURE in Pennsylvania has been accompanied by "a lowering of clinical thresholds for performing cholecystectomy," Jose Escarce, MD, et al., University of Pennsylvania-Philadelphia, report in a study published in the May 24/31 Journal of the American Medical Association. "Compared with patients who underwent surgery before the laparoscopic procedure became available, cholecystectomy patients in the laparoscopic era had lower acuity and severity of the primary gallstone-related illness, as manifested by higher proportions of patients with uncomplicated gallstone disease and higher proportions of elective operations," the authors found.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.